Tetragon Partners GP as of June 30, 2026
Portfolio Holdings for Tetragon Partners GP
Tetragon Partners GP holds 36 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Uipath Cl A (PATH) | 53.0 | $336M | 31M | 10.87 | |
| Kolibri Global Energy Com New (KGEI) | 5.3 | $34M | 6.8M | 4.95 | |
| Autolus Therapeutics Spon Ads (AUTL) | 2.4 | $15M | 9.5M | 1.60 | |
| Lyft Cl A Com (LYFT) | 2.3 | $15M | 1.0M | 14.61 | |
| Definium Therapeutics Com Shs (DFTX) | 2.1 | $14M | 287k | 47.04 | |
| Workiva Com Cl A (WK) | 1.9 | $12M | 250k | 48.51 | |
| Silence Therapeutics Ads Call Option (SLN) | 1.8 | $12M | 1.1M | 10.98 | |
| Sprinklr Cl A (CXM) | 1.8 | $11M | 2.2M | 5.16 | |
| Mbx Biosciences (MBX) | 1.8 | $11M | 204k | 55.20 | |
| Alkami Technology (ALKT) | 1.7 | $11M | 600k | 18.12 | |
| Celldex Therapeutics Com New (CLDX) | 1.7 | $11M | 290k | 37.21 | |
| Relay Therapeutics (RLAY) | 1.7 | $11M | 570k | 18.71 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.7 | $11M | 131k | 81.51 | |
| Pharvaris N V (PHVS) | 1.6 | $10M | 296k | 34.58 | |
| Alkermes SHS (ALKS) | 1.6 | $10M | 190k | 52.40 | |
| Immunovant (IMVT) | 1.6 | $9.9M | 256k | 38.53 | |
| Agios Pharmaceuticals (AGIO) | 1.5 | $9.5M | 256k | 37.11 | |
| Axsome Therapeutics Call Option (AXSM) | 1.3 | $8.6M | 35k | 244.77 | |
| Dyne Therapeutics (DYN) | 1.2 | $7.9M | 357k | 22.21 | |
| Ionis Pharmaceuticals (IONS) | 1.2 | $7.7M | 97k | 79.29 | |
| Harmony Biosciences Hldgs In (HRMY) | 1.2 | $7.3M | 201k | 36.41 | |
| Krystal Biotech (KRYS) | 1.2 | $7.3M | 20k | 371.67 | |
| Annexon (ANNX) | 1.1 | $7.1M | 1.2M | 5.71 | |
| Celcuity (CELC) | 1.1 | $6.7M | 64k | 104.62 | |
| Warner Bros Discovery Com Ser A (WBD) | 1.0 | $6.7M | 250k | 26.66 | |
| Nektar Therapeutics Com New (NKTR) | 1.0 | $6.1M | 87k | 69.81 | |
| Amylyx Pharmaceuticals Call Option (AMLX) | 0.9 | $5.5M | 306k | 17.96 | |
| ACADIA Pharmaceuticals (ACAD) | 0.7 | $4.2M | 168k | 25.30 | |
| Ultragenyx Pharmaceutical Call Option (RARE) | 0.5 | $3.3M | 100k | 33.39 | |
| Cue Biopharma (CUE) | 0.5 | $3.0M | 94k | 31.56 | |
| Snowflake Com Shs (SNOW) | 0.4 | $2.5M | 10k | 254.50 | |
| Karyopharm Therapeutics Com New Call Option (KPTI) | 0.4 | $2.4M | 250k | 9.77 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $2.1M | 400k | 5.29 | |
| Tectonic Therapeutic (TECX) | 0.3 | $1.6M | 47k | 34.38 | |
| Monte Rosa Therapeutics (GLUE) | 0.2 | $1.4M | 56k | 24.20 | |
| Tenax Therapeutics Com New Call Option (TENX) | 0.2 | $1.1M | 75k | 14.55 |
